secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K/A
Filed at:   2021-10-26T23:59:59+00:00
Accession:  0001493152-21-026300
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics corrects typo in prior 8-K; confirms 320K share and warrant sale for $400K
--------------------------------------------------------------------------------

- Amendment corrects share count to 320,000 shares of common stock and warrants for 320,000 shares.
- Gross proceeds from sale to accredited investors total $400,000, consummated October 20, 2021.
- Warrants allow purchase of 320,000 shares of common stock; terms not specified in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315221026300/0001493152-21-026300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315221026300/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-026300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer